{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:48:33Z","timestamp":1761392913431},"reference-count":13,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":614,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2000,4,20]]},"abstract":"<jats:p> <jats:bold>Abstract<\/jats:bold> It is estimated that more than 100 children die of influenza\u2010associated encephalopathy (influenza encephalopathy) every year in Japan. Influenza encephalopathy is distinct from Reye\u2019s syndrome. Specifically, 20% of influenza encephalopathy patients exhibit bilateral thalamic necrosis on neuroimaging, a lesion referred to as acute necrotizing encephalopathy (ANE). Influenza encephalopathy may develop by the same pathogenetic mechanisms as ANE, possibly via vasoactive substances or a process leading to vasoconstriction in the central nervous system (CNS). A novel substitution at the receptor\u2010binding site (Tyr 137 to Phe) was reported to be found exclusively in influenza type A (H3N2) viruses isolated from patients with influenza encephalopathy, suggesting that encephalopathy may be caused by a variant influenza type A (H3N2) virus. Recently, it has been reported that cytokines may mediate the disease and that a high plasma concentration of interleukin\u20106 could be an indicator of progression to encephalopathy. Although it is unknown whether influenza virus invades the CNS, amantadine therapy for influenza encephalopathy has been tried in Japan, in patients in whom influenza type A infection has been demonstrated by rapid antigen detection tests.<\/jats:p>","DOI":"10.1046\/j.1442-200x.2000.01200.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:48:46Z","timestamp":1047487726000},"page":"215-218","source":"Crossref","is-referenced-by-count":61,"title":["Influenza\u2010associated encephalopathy in Japan: Pathogenesis and treatment"],"prefix":"10.1111","volume":"42","author":[{"given":"Norio","family":"Sugaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"2699","article-title":"Acute encephalitis and encephalopathy at the height of influenza in childhood.","volume":"55","author":"Togashi T","year":"1997","journal-title":"Nippon Rinsho"},{"key":"e_1_2_8_3_2","first-page":"880","article-title":"Neurological outcome associated with influenza viral infection.","volume":"55","author":"Kamimura N","year":"1997","journal-title":"Nippon Rinsho"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.1998.tb01925.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12449-2"},{"key":"e_1_2_8_6_2","first-page":"16","article-title":"IL\u20106 and TNF\u2010alpha in cerebrospinal fluid from infantile encephalitis\u2010encephalopathy patients during influenza seasons.","volume":"103","author":"Togashi T","year":"1999","journal-title":"Nippon Shonika Gakkai Zasshi"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<420::AID-JMV16>3.0.CO;2-T"},{"key":"e_1_2_8_8_2","doi-asserted-by":"crossref","unstructured":"SugayaN&MiuraM.Amantadine therapy for influenza type A\u2010associated encephalopathy.Pediatr. Infect. Dis. J.1999;18: 734.","DOI":"10.1097\/00006454-199908000-00019"},{"key":"e_1_2_8_9_2","first-page":"822","article-title":"Influenza A virus associated with acute encephalopathy.","volume":"133","author":"Delorme L","year":"1979","journal-title":"Am. J. Dis. Child."},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.11150\/kansenshogakuzasshi1970.73.778"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(96)00063-0"},{"key":"e_1_2_8_12_2","first-page":"439","article-title":"Acute encephalopathy with bilateral thalamotegmental involvement in infants and children: Imaging and pathology findings.","volume":"16","author":"Yagishita A","year":"1995","journal-title":"Am. J. Neuroradiol."},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007050050491"},{"key":"e_1_2_8_14_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0891-5520(20)30120-3","article-title":"Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infection.","volume":"1","author":"Tominack RL","year":"1987","journal-title":"Infect. Dis. Clin. N. Am."}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-200x.2000.01200.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-200x.2000.01200.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T08:37:41Z","timestamp":1698568661000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-200x.2000.01200.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,20]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4,20]]}},"alternative-id":["10.1046\/j.1442-200x.2000.01200.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-200x.2000.01200.x","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,20]]}}}